Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2651 |
|
| Actual shortage: | 257 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2385 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-02-25 | 2021-04-08 | 134727 |
| ACT CELECOXIB | 200MG | CAPSULE | Actual shortage | 2021-02-18 | 2021-05-06 | 134357 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Actual shortage | 2021-02-18 | 2021-02-18 | 134352 |
| TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-18 | 2021-03-18 | 134349 |
| TEVA-EMTEC-30 | 300MG 30MG | TABLET | Resolved | 2021-02-18 | 2021-03-04 | 134346 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-18 | 2021-05-13 | 134343 |
| TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-02-18 | 2021-04-15 | 134340 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-02-18 | 2021-03-04 | 134337 |
| TEVA-IMATINIB | 400MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134334 |
| TEVA-EZETIMIBE | 10MG | TABLET | Resolved | 2021-02-18 | 2021-03-11 | 134331 |
| TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-02-11 | 2021-02-25 | 133788 |
| TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-02-11 | 2021-03-04 | 133785 |
| TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-02-11 | 2021-03-25 | 133782 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-02-11 | 2021-03-11 | 133779 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-05-27 | 133776 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-04-29 | 133770 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-05 | 2021-02-25 | 133476 |
| TEVA-VARENICLINE | 0.5MG | TABLET | Actual shortage | 2021-02-05 | 2021-02-05 | 133473 |
| ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-02-05 | 2021-04-01 | 133470 |
| TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2021-02-05 | 2021-02-11 | 133467 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |